Menu Search
Equities

Biosino Bio-Technology and Science Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
8247:HKG.HZ

Biosino Bio-Technology and Science Inc

Actions
  • Price (HKD)5.49
  • Today's Change0.43 / 8.50%
  • Shares traded240.05k
  • 1 Year change+785.48%
  • Beta0.0479
Data delayed at least 15 minutes, as of Feb 16 2026 02:39 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Biosino Bio-Technology and Science Inc is a China-based company primarily engaged in the research and development, manufacture, sale and distribution of in-vitro diagnostic reagents. The Company’s main products include clinical chemistry, immunological diagnostic products, molecular diagnostic products, hematology diagnostic products, medical clinical nutrition diagnostic products and related analytical instruments and raw materials. The Company’s products are mainly used for the diagnosis of liver function, lipids, renal function, myocardial, special proteins, trace elements, and sugar metabolism. The Company mainly operates its businesses in the domestic market.

  • Revenue in HKD (TTM)254.60m
  • Net income in HKD-53.54m
  • Incorporated1988
  • Employees471.00
  • Location
    Biosino Bio-Technology and Science IncChangping Business Hotel Opposite,No.27,Chaoqian Road, Science and TechnologyIndustrial Park, Changping DistrictBEIJING 102200ChinaCHN
  • Phone+86 1 080117700
  • Fax+86 1 080117026
  • Websitehttps://www.zhongsheng.com.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.